PTPRQ, PLEKHB2, IL1RAPL1, and EXT1 are predicted to be involved in biological processes such as heart and large blood vessel development, as well as cardiac phenotypes such as arrhythmias, valve diseases, and cardiomyopathy (Supplementary Table 2). Here, PTPRQ is linked to cardiomyopathy.